Exp Clin Endocrinol Diabetes 2005; 113(1): 31-34
DOI: 10.1055/s-2004-830523
Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Identification of a Novel Calcium-Sensing Receptor Gene Mutation Causing Familial Hypocalciuric Hypercalcemia by Single-Strand Conformation Polymorphism Analysis

P. Felderbauer1 , P. Hoffmann1 , W. Klein2 , K. Bulut1 , N. Ansorge1 , J. T. Epplen2 , F. Schmitz1 , W. E. Schmidt1
  • 1Department of Internal Medicine I, St. Josef Hospital, Ruhr-University of Bochum, Germany
  • 2Department of Human Genetics, Ruhr-University Bochum, Germany
Further Information

Publication History

Received: December 2, 2003

Accepted: May 13, 2004

Publication Date:
21 January 2005 (online)

Abstract

Calcium-sensing receptor gene (CASR) mutations that alter the function of the G protein coupled Ca2+-sensing receptor are reported in patients with familial hypocalciuric hypercalcemia (FHH), autosomal dominant hypocalcemia (ADH), and neonatal severe hyperparathyroidism (NSHPT). In search for novel disease causing mutations in the CASR gene, we screened exons 2 - 7 of the CASR gene of a family with FHH using single-strand conformation polymorphism analysis. We identified a novel CASR mutation (c.518 T > C; L173 P) in exon 4 encoding for the extracellular domain of the Ca2+-sensing receptor. This region seems to represent a hot spot within the CASR gene with at least 13 reported disease causing mutations thus far.

References

  • 1 Brauner-Osborne H, Jensen A A, Sheppard P O, O'Hara P, Krogsgaard-Larsen P. The agonist-binding domain of the calciumsensing receptor is located at the amino-terminal domain.  J Biol Chem. 1999;  274 18382-18386
  • 2 Brown E M, MacLeod R J. Extracellular calcium sensing and extracellular calcium signaling.  Physiol Rev. 2001;  81 239-297
  • 3 Chou Y H, Brown E M, Levi T, Crowe G, Atkinson A B, Arnqvist H J, Toss G, Fuleihan G E, Seidman J G, Seidman C E. The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3 q in four unrelated families.  Nat Genet. 1992;  1 295-300
  • 4 Hu J, Hauache O, Spiegel A M. Human Ca2 + receptor cysteine-rich domain. Analysis of function of mutant and chimeric receptors.  J Biol Chem. 2000;  275 16382-16389
  • 5 Janicic N, Soliman E, Pausova Z, Seldin M F, Riviere M, Szpirer J, Szpirer C, Hendy G N. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3 q13. 3 - 21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16.  Mamm Genome. 1995;  6 798-801
  • 6 Pearce S H, Wooding C, Davies M, Tollefsen S E, Whyte M P, Thakker R V. Calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia with recurrent pancreatitis.  Clin Endocrinol. 1996;  45 675-680
  • 7 Pollak M R, Brown E M, Chou Y H, Hebert S C, Marx S J, Steinmann B, Levi T, Seidman C E, Seidman J G. Mutations in the human Ca(2 +)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.  Cell. 1993;  31 1297-1303
  • 8 Stuckey B G, Gutteridge D H, Kent G N, Reed W D. Familial hypocalciuric hypercalcemia and pancreatitis: no causal link proven.  Aust N Z J Med. 1990;  20 718-719
  • 9 Ward B K, Stuckey B G, Gutteridge D H, Laing N G, Pullan P T, Ratajczak T. A novel mutation (L174 R) in the Ca2 + -sensing receptor gene associated with familial hypocalciuric hypercalcemia.  Hum Mutat. 1997;  10 233-235

Peter Felderbauer

Department of Medicine I at St. Josef-Hospital
Laboratory for Experimental Gastroenterology
Ruhr-University of Bochum

Gudrunstraße 56

44791 Bochum

Germany

Phone: + 492345092378

Fax: + 49 23 45 09 23 09

Email: peter.felderbauer@rub.de

    >